Squarepoint Ops LLC - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 29 filers reported holding SEELOS THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$72,000
-53.5%
29,690
-4.4%
0.00%
-100.0%
Q1 2021$155,000
-39.5%
31,060
-80.8%
0.00%
-50.0%
Q4 2020$256,000
+2744.4%
161,804
+831.3%
0.00%
Q1 2020$9,000
-67.9%
17,374
-18.0%
0.00%
Q4 2019$28,000
+33.3%
21,200
-9.1%
0.00%
Q3 2019$21,000
-66.7%
23,330
-18.5%
0.00%
-100.0%
Q2 2019$63,00028,6290.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 508,000$249,0000.10%
1492 Capital Management LLC 150,000$74,0000.09%
Uniplan Investment Counsel, Inc. 2,069,121$1,014,0000.08%
ARDSLEY ADVISORY PARTNERS LP 70,000$34,0000.01%
Spark Investment Management LLC 35,210$17,0000.01%
TOCQUEVILLE ASSET MANAGEMENT L.P. 191,000$94,0000.00%
WealthPLAN Partners, LLC 20,000$15,0000.00%
Procyon Advisors, LLC 2,500$1,0000.00%
Renaissance Technologies 1,078,379$529,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SEELOS THERAPEUTICS INC shareholders